Clinical Trial Update: A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009) [Phase 1]

View source ↗

Summary

Phase 1 study update of Calderasib (MK-1084) with Midazolam and Digoxin in healthy participants, status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Calderasib (MK-1084)
• DIGOXIN (Digoxin)
• Midazolam (Midazolam)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: COMPLETED